Stay updated on PF-06439535 vs Bevacizumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the PF-06439535 vs Bevacizumab in NSCLC Clinical Trial page.

Latest updates to the PF-06439535 vs Bevacizumab in NSCLC Clinical Trial page
- CheckyesterdayChange DetectedRevision updated the page version from v3.5.4 to v3.5.5. This reflects a small update to the page without changing the study details or other visible content.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe revision tag on the page was updated from v3.5.3 to v3.5.4, replacing the previous version indicator. This reflects a minor update to the page's version history without altering visible content.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site release rather than any change to the underlying clinical trial information.SummaryDifference0.0%

- Check51 days agoChange DetectedAdded Valparaiso and Araucania locations, including Temuco, Araucania, Chile (4810469) and Viña del Mar, Valparaiso, Chile (2540364). Removed Temuco, Región de la Araucanía, Chile (4810469) and Viña del Mar, Región de Valparaíso, Chile (2540364); revision updated from v3.5.0 to v3.5.2.SummaryDifference0.2%

- Check80 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check94 days agoChange DetectedRevision: v3.4.3 was added and the previous v3.4.2 revision was removed.SummaryDifference0.0%

Stay in the know with updates to PF-06439535 vs Bevacizumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PF-06439535 vs Bevacizumab in NSCLC Clinical Trial page.